Session information

Symposium

Symposium 16 Optimal DAPT therapy for high bleeding risk patients

Fri. Sep 20, 2019 8:00 AM - 9:30 AM Room 2 (Bldg4,1F)

Chair:Davide Capodanno(AOU Policlinico-Vittorio Emanuele, University of Catania, Italy), Junya Ako(Kitasato University), Peter Smits(FESC, The Netherlands)

Simultaneous interpretation

+Add all to schedule

[S16-K] Overview of current evidence ofl DAPT therapy for high bleeding risk (HBR) patients

^○Valgimigli Marco (Bern University Hospital, Switzerland)

[S16-1] A consensus from the academic reserch consortium for high bleeding risk

^○Marie Claude Poisson Morice (Institut Cardiovasculaire Paris Sud, France)

[S16-2] The prevalence and event rate of high bleeding risk patients -Insights from the CREDO-Kyoto registry Cohort-2-

^○Natsuaki Masahiro (Saga University)

[S16-3] Does tissue coverage after DES implantation matter? A Protocol of MASTER-DAPT OCT Japan substudy

^○Ozaki Yukio (Fujita Health University Hospital)

[S16-4] Monotherapy in HBR patientInsights from PENDULUM Mono trial

^○Nakamura Masato (Toho University Ohashi Medical Center)

Authentication

Please log in with your participant account.
» Participant Log In

▲